Global Whole Genome And Exome Sequencing Market Projected to Grow at 24.8% CAGR, Reaching $6.11 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Whole Genome And Exome Sequencing Industry Market Size Be by 2025?
The overall market for whole genome and exome sequencing has experienced substantial expansion recently, with its valuation projected to climb from two-point-oh-two billion USD in 2024 to two-point-five-two billion USD in 2025, reflecting a compound annual growth rate of twenty-four-point-five percent; this upward trajectory during the past period stems from multiple factors including the reduction in sequencing expenses, an increase in the prevalence of genetic conditions, expanding utilization in clinical settings, growth of genomic data storage facilities, and progress in the field of bioinformatics.

What's the Long-Term Growth Forecast for the Whole Genome And Exome Sequencing Market Size Through 2029?
Exponential expansion is anticipated within the market for whole genome and exome sequencing over the forthcoming period, projecting a value reaching $6.11 billion by 2029, fueled by a compound annual growth rate (CAGR) of 24.8%. This considerable growth throughout the prediction phase stems from several key factors, notably global population genomics endeavors, an increasing need for personalized medical treatments, breakthroughs in sequencing at the single-cell level, broader use of non-invasive prenatal testing, and its utility in investigating rare illnesses. Key directional shifts influencing the market during this time encompass greater incorporation into clinical settings, swift technological improvements in sequencing methods, the emergence of large-scale genomic research projects, the merging of artificial intelligence (AI) and machine learning (ML) capabilities, and the broadening scope of its deployment in cancer studies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

What Are the Key Growth Drivers Fueling the Whole Genome And Exome Sequencing Market Expansion?
Anticipated increases in the need for tailored medical approaches are predicted to fuel the expansion of the market encompassing whole genome and exome sequencing moving forward. Personalized medicine represents a healthcare strategy where treatment plans and interventions are customized precisely to each patient's unique attributes, taking into account elements like their genetic profile, surroundings, and daily habits. This diagnostic technique, whole genome and exome sequencing, directly supports personalized medicine by offering an in-depth examination of a person's hereditary information, thereby enabling healthcare providers to make treatment choices uniquely suited to their individual genetic, environmental, and lifestyle contexts. To illustrate this trend, data released in October 2022 by the Personalized Medicine Coalition (PMC), an American entity dedicated to advancing awareness and use of personalized medicine, indicated that over 75,000 genetic testing options and 300 patient-specific drugs were projected to be available commercially during 2022. Moreover, the Drug Evaluation and Research Center (CDER) within the Food and Drug Administration authorized 37 novel molecular treatments in 2022; notably, among the 35 therapeutic NMEs, close to 34 percent, equating to twelve specific products, were categorized as personalized. Consequently, the escalating requirement for individualized healthcare solutions serves as the primary impetus behind the expansion observed in the whole genome and exome sequencing industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

What Are the Key Trends Driving Whole Genome And Exome Sequencing Market Growth?
Within the entirety of the whole genome and exome sequencing arenas, leading enterprises are intensifying efforts toward creating sophisticated technological instruments, particularly ultra-fast next-generation sequencing (NGS) analysis, intending to secure a superior market position. This rapid NGS analysis represents a significant technological leap, allowing for the swift processing of NGS data, which drastically cuts down the duration typically needed for genomic interpretation. A prime illustration of this advancement occurred in January 2023 when US firm QIAGEN Digital Insights (QDI) introduced its platform for ultra-fast NGS analysis; this offering boasts capabilities like analyzing an entire genome for just one dollar in cloud expenses within twenty-five minutes, thereby championing efficiency, cost-effectiveness, and expanded reach, making this innovation highly relevant to the sequencing markets by facilitating quicker strategic choices and broader application of individualized healthcare.

How Is the Whole Genome And Exome Sequencing Market Segmented?
The whole genome and exome sequencingmarket covered in this report is segmented -

1) By Product Type: Kits; Instruments
2) By Workflow: Whole Genome Sequencing (WGS); Whole Exome Sequencing (WES)
3) By Applications: Diagnostics; Cancer; Monogenic Disorders; Diabetes; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research; Other Applications
4) By End user: Research Center; Academic And Government Institutions; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:
1) By Kits: Library Preparation Kits; Target Enrichment Kits; DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Third-Generation Sequencing Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

Which Companies Are Leading the Charge in Whole Genome And Exome Sequencing Market Innovation?
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

Which Regions Are Leading the Global Whole Genome And Exome Sequencing Market in Revenue?
North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.